Personal identification

Full name

Michael Sapateiro Luís

Citation names

• Luís, Michael

Author identifiers

Ciência ID

F41A-B610-DBC5

ORCID iD

0000-0002-6625-5183

Telephones

Mobile phone

• 919164538 (Personal)

Websites

• www.linkedin.com/in/michael-luis-55862a42 (Social media)

Knowledge fields

• Medical and Health Sciences - Clinical Medicine - Oncology

Languages

Language	Speaking	Reading	Writing	Listening	Peer-review
Portuguese (Mother tongue)
German (Mother tongue)
English	Advanced (C1)	Proficiency (C2)	Advanced (C1)	Proficiency (C2)

	Degree	Classification
2021 Attended	Cuidados Paliativos (Doutoramento) Universidade do Porto Faculdade de Medicina, Portugal
2018 Concluded	Pós-graduação em Cuidados Paliativos (Pós-Graduação) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2016 Concluded	Internato Médico Complementar - Oncologia Médica (Especialização pós-licenciatura) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2013 Concluded	Oncologia (Mestrado) Major in Área de especialização: Oncologia Clínica Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal "Trastuzumab in advanced Gastric Cancer: proportion of eligible cases in a single Centre" (THESIS/DISSERTATION)
2009/07 Concluded	Medicina (Mestrado integrado) Universidade do Porto Faculdade de Medicina, Portugal

Other Careers

	Category Host institution	Employer
2024 - Current	Assistente graduado (Médica)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2018 - 2024	Assistente (Médica)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2016 - 2017	Assistente graduado (Médica)	Centro Hospitalar de Trás-os-montes e Alto Douro EPE, Portugal
2011 - 2016	Interno (Médica)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2010/01 - 2010/12	Interno (Médica)	Unidade Local de Saúde de Matosinhos EPE, Portugal

Publications

Journal article

Ferraz-Gonçalves JA; Silva I; Redondo P; Luís MS. "Aggressiveness in systemic anticancer therapy at the end of life in an oncology center.". Porto biomedical journal (2024): http://europepmc.org/abstract/med/38464546. 10.1097/j.pbj.0000000000000248 Ferraz-Gonçalves JA; Alves A; Silva ÁJ; Valente AC; Pina A; Lima Á; Antunes D; et al. "Factors Associated With Long Survival in Patients With Cancer Admitted to Palliative Care: An Exploratory Study.". Journal of palliative care (2024): http://europepmc.org/abstract/med/38374645. 10.1177/08258597241231005 Lima, Joana; Gago, Patrícia; Rocha, Mariana; Grilo, Inês; Gomes, Rosa; Luís, Michael; Sarmento, Teresa; et al. "Role of intravenous iron in the treatment of anemia in patients with gastrointestinal tract tumors undergoing chemotherapy: a single-center, observational study". International Journal of General Medicine Volume 11 (2018): 331-336. https://doi.org/10.2147/ijgm.s165947. 10.2147/ijgm.s165947 Luis, Michael; Boussios, Stergios; Dumas, Lucy; Banerjee, Susana. "Systemic management of malignant ovarian germ cell tumors in older women: two case reports and a review of the literature". Cancer Breaking News 4 1 (2016): 26-35. https://doi.org/10.19156/cbn.2016.0006. 10.19156/cbn.2016.0006 Luis M; Tavares A; Carvalho LS; Lara-Santos L; Araújo A; de Mello RA. "Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapies.". World journal of gastroenterology (2013): http://europepmc.org/abstract/med/24151357. 10.3748/wjg.v19.i38.6383